Related Experiment Video
Updated: May 17, 2026
09:52
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?
Phillip Shelton1, Anil K Jaiswal
1Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
Summary
The transcription factor Nrf2 regulates antioxidant genes. Dysregulation of Nrf2 signaling can promote cancer, highlighting its dual role as a tumor suppressor and proto-oncogene.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key regulator of cellular defense mechanisms against oxidative stress.
- Nrf2 controls a network of antioxidant and cytoprotective genes essential for maintaining redox homeostasis.
- Nrf2 activity is intricately regulated through signaling pathways, with distinct phases including basal state, preinduction, induction, and postinduction responses.
Purpose of the Study:
- To elucidate the regulatory mechanisms of Nrf2.
- To discuss the Nrf2-inducible genes involved in cellular protection.
- To explore the dual role of Nrf2 in cancer, acting as both a tumor suppressor and a proto-oncogene.
Main Methods:
- Review of scientific literature on Nrf2 regulation and function.
- Analysis of Nrf2-inducible genes including antioxidant, antiapoptotic, metabolic, and drug efflux transporter genes.
- Discussion of Nrf2's role in carcinogenesis and therapeutic targeting.
Main Results:
- Nrf2 regulates genes such as NQO1, HO-1, GCLC, Bcl-2, G6PD, ABCG2, and MRP transporters.
- Nrf2 functions as a tumor suppressor by detoxifying the cellular environment under normal conditions.
- Aberrant Nrf2 signaling can be exploited by oncogenes, leading to its proto-oncogenic role.
Conclusions:
- Nrf2's complex regulatory network presents opportunities for disruption in cancer development.
- Nrf2's dual role necessitates careful consideration for its therapeutic application in cancer treatment.
- Targeting Nrf2 pathways offers potential strategies for cancer therapy.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
02:23Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...